Plain-English translation of NCT06524557 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether special ultrasound imaging techniques can help doctors reliably tell the difference between benign (noncancerous) and malignant (cancerous) liver tumors. Researchers will look at ultrasound images from 200 people to see how accurate these imaging methods are, especially in people with chronic liver disease.
Currently, doctors often need to do a biopsy (take a tissue sample) to know for sure whether a liver tumor is benign or malignant. This study hopes to show that improved ultrasound imaging alone might be able to make this diagnosis noninvasively, which would spare patients from the risks and discomfort of a biopsy.
This is a retrospective study, which means researchers will review medical records and ultrasound images you've already had — you won't need new visits or tests. The study will collect your demographic information, clinical history, and blood work results, then analyze your existing ultrasound images to see how well they predicted whether your tumor was benign or malignant based on your biopsy or surgery results.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China
Enrollment target
~200 participants
Started
January 2018
Primary completion
December 2025
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhou Huihui, M.M.
Department of Ultrasonic Medicine, The First Affiliated Hospital of Air Force Medical University